Search research articles
Contact Us
Filters
Showing results (101-110 of 120) with videos related to
Page
of 12
Sort By:
Annals of the Rheumatic Diseases
|
March 22, 2005
Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome
I Krause, S Lev, A Fraser, et al.
Proteins
|
December 19, 2000
Docking molecules by families to increase the diversity of hits in database screens: computational strategy and experimental evaluation
A I Su, D M Lorber, G S Weston, et al.
Clinical and Experimental Immunology
|
May 1, 1997
Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)
J George, M Blank, M Hojnik, et al.
Transplantation Proceedings
|
May 14, 2003
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation
R N Formica, K M Lorber, A L Friedman, et al.
Transplantation Proceedings
|
March 26, 2004
The evolving experience using everolimus in clinical transplantation
R N Formica, K M Lorber, A L Friedman, et al.
Harefuah
|
June 1, 1988
[Oral gold for rheumatoid arthritis]
I Wigler, D Caspi, M Lorber, et al.
Transplantation Proceedings
|
December 26, 2001
The evolving role of tor inhibitors for individualizing posttransplant immunosuppression
M I Lorber, G P Basadonna, A L Friedman, et al.
Clinical Reviews in Allergy & Immunology
|
October 17, 1998
Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens
I J Alosachie, J W Terryberry, D Mevorach, et al.
Journal of Clinical Laboratory Analysis
|
January 1, 1995
Myelin- and microbe-specific antibodies in Guillain-Barré syndrome
J Terryberry, M Sutjita, Y Shoenfeld, et al.
Lupus
|
April 1, 1995
Anti-neuronal antibodies in antiphospholipid syndrome with central nervous system involvement: the difference from systemic lupus erythematosus
M Tishler, I Alosachie, Y Chapman, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 120) with videos related to
Sort By:
Page
of 12
Annals of the Rheumatic Diseases
|
March 22, 2005
Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome
I Krause, S Lev, A Fraser, et al.
Proteins
|
December 19, 2000
Docking molecules by families to increase the diversity of hits in database screens: computational strategy and experimental evaluation
A I Su, D M Lorber, G S Weston, et al.
Clinical and Experimental Immunology
|
May 1, 1997
Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)
J George, M Blank, M Hojnik, et al.
Transplantation Proceedings
|
May 14, 2003
Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation
R N Formica, K M Lorber, A L Friedman, et al.
Transplantation Proceedings
|
March 26, 2004
The evolving experience using everolimus in clinical transplantation
R N Formica, K M Lorber, A L Friedman, et al.
Harefuah
|
June 1, 1988
[Oral gold for rheumatoid arthritis]
I Wigler, D Caspi, M Lorber, et al.
Transplantation Proceedings
|
December 26, 2001
The evolving role of tor inhibitors for individualizing posttransplant immunosuppression
M I Lorber, G P Basadonna, A L Friedman, et al.
Clinical Reviews in Allergy & Immunology
|
October 17, 1998
Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens
I J Alosachie, J W Terryberry, D Mevorach, et al.
Journal of Clinical Laboratory Analysis
|
January 1, 1995
Myelin- and microbe-specific antibodies in Guillain-Barré syndrome
J Terryberry, M Sutjita, Y Shoenfeld, et al.
Lupus
|
April 1, 1995
Anti-neuronal antibodies in antiphospholipid syndrome with central nervous system involvement: the difference from systemic lupus erythematosus
M Tishler, I Alosachie, Y Chapman, et al.
Page
of 12